Submissions

This journal is not accepting submissions at this time.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The authorship statement form (contained in the Copyright Notice below) has been read and accepted by all the contributing authors.
  • The submission file is in Microsoft Word pr RTF document file format.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • The text, if submitted to a peer-reviewed section of the journal (e.g. Articles), the instructions in Ensuring a Blind Review have been followed.
  • A structured abstract of no more than 250 words has been included with the text. A list of three to five keywords has been given, and placed after the Abstract.
  • Listed references (i.e. bibliography at the end) are based on the journal requirements style.

Author Guidelines

Important Information

  1. Submission of a paper will be held to imply that the manuscript contains original unpublished work and is not being submitted for publication elsewhere.
  2. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out.
  3. It is understood that with submission of this article the authors have complied with the institutional policies governing the humane and ethical treatment of the experimental subjects, and that they are willing to share the original data and materials if so requested.
  4. Conflict of Interest? Full Disclosure: In addition to complete contact/address of employer/institutional affiliation for all authors, all other relationships that may be perceived to potentially conflict the objectivity of any author must be fully disclosed in a footnote to the manuscript.

Authors are requested to submit the original manuscript 2 copies and the electronic version to the following address:

To
The Editor- In - Chief
Stamford Journal of Pharmaceutical Sciences
Department of Pharmacy
51, Siddeswari Road , Dhaka-1212
Stamford University, Bangladesh

or email
editorsjps@gmail.com

Please, include full contact information- corresponding author's name, e-mail address, telephone and fax numbers and full postal address. Only manuscripts written in English should be submitted. Manuscripts submitted by facsimile transmission will not be considered. If a manuscript sent to the authors for revision is not returned to the editor within 3 months, it will be treated as a new article. When the article is published, the authors are considered to transfer all rights of the manuscript to the Publisher.

ORGANIZATION AND STYLE OF MANUSCRIPTS

  1. Original and two copies of the manuscript should be sent to the editor. Manuscript should be typed on A4 size papers.
  2. Manuscript should be written as clearly and concisely as possible. The author is responsible for providing the correct nomenclature which must be consistent and unambiguous.
  3. All tables and figures should be inserted in the text, not exceeding the text margins.
  4. Manuscript should be typed on one side of the paper only using 1.5 line spacing with a margin of 3 cm on all sides. Since articles will be printed by offset printing technique, author are requested to submit their manuscripts on 3.5'' diskettes/CD, styled as ‘Microsoft Word' files. Font should be 'Times New Roman' with 12 pt font size.
  5. Page numbers must be placed on the back of pages with pencil.
  6. Author (s)' names (full names, surnames with capital letters, no title) should be written allowing 3 line spaces from the title of the article. Having more than one author, the names should be separated with commas. By using numbers as superscripts, the institution and postal addresses of authors must be indicated in the next line.
  7. Title page of the manuscript should include title (as informative and concise as possible), author (s)' names and their complete postal addresses. Corresponding author, indicated by an asterisk (*), should indicate his/her fax number, telephone number and e-mail address, if available, at the bottom of the title page.
  8. All tables and figures must be cited in the text consecutively and their number must be written in parenthesis. Each Table and Figure (chemical formulas, graphics, photographs, chromatographs, spectra, etc) must have a descriptive title at the top of the table, at the bottom of the figure with on line space and they should be numbered with Arabic numerals (1,2,3, etc).They should be referred as 'Table 1' and 'Figure 1' in the text. Any lettering (symbols, numbers, etc) in the illustrations should be used in a consistent way and be of consistent size, keeping in mind that they should remain legible after reduction to one column width (8.5 cm) in the journal format. Descriptive titles should be printed with 11 pt font size. Heading should not exceed the length of the tables and figures. Any footnotes to a table must be collected below and referred in the table by superscript letters (a, b, etc). There must be adequate space to separate the text and figures/tables. Abbreviations must be included in the text in parentheses. Equations and formulas must be numbered consecutively and their numbers must be written right justified in parenthesis. They must be referred within the text by using their numbers in parentheses. Complex chemical formulas must be prepared as figures.
  9. In each paragraph, 5 letter space indentations must be done.
  10. Manuscripts, including figures and tables, should not exceed 30 pages for reviews, 20 for research articles, 10 for technical notes and short communications and 5 pages for letters to the editor.
  11. Manuscripts should be organized as follows: title page, abstracts, key words, introduction, experimental, results, discussion, conclusion and references. Each section must be separated with 2 line spaces. The section titles (Introduction, Experimental, Results, Discussion, Conclusion and References) must be written with bold capital letters using 12 pt font sizes. Subtitles should be written in italic. There should be no line space between the section headings and text.

    12. Title: Font must be 14 pt, bold, in capital letters and 'Times New Roman'.

    Abstracts: They should be written in English containing no more than 200 words, 10 pt and italic. Abstracts should be put in borders.

    Key Words: 3-6 English keywords separated by commas must be included in the manuscript just below the abstracts.

    Introduction: It should contain a clear statement of the aim and novelty of the study.

    Experimental: Materials and experimental procedures should be described in sufficient detail.

    Results: The results must be clearly and concisely described with the help of appropriate illustrative material. Any additional cost for color figures will be entirely charged to the authors.

    Discussion: Discussion should deal with the interpretation of the results.

    Conclusion: Significant findings should be summarized briefly in a paragraph.

    Acknowledgement: If necessary, this section should be given at the end of the text, just before the references.

    References: References inside the text should be written in alphabetically by author name and year of publication. In case of more than two authors references should be inside the text written as (Alam et al. 2008). The Style of references is given below:

    Journal: Alam MA, Akter R, Subhan N, Rahman MM, Majumder MM, Nahar L, Sarker SD. (2008) Antidiarrhoeal property of the hydroethanolic extract of the flowering tops of Anthocephalus cadamba. Brazilian J. Pharmacog. 18(2): 155-159.

    Book: Ghani A. (2003) Medicinal Plants of Bangladesh, 2nd Ed. pp. 331-332 The Asiatic Society of Bangladesh, Dhaka.

    Article in Book: Saito H, Nomura Y. (1989) Screening methods for drug evaluation 3. In: Pharmaceutical Research and Development, edited by Suzuki L, Tanaka H, Yajima H, Fukuda H, Sezaki H, Koga K, Hirobe M, Nakajime T, p. 22, Hirokawa, Tokyo.

    Conference proceedings: Jahan MS, Mun SP. (2004) Soda-Anthraquinone pulping of Trema orientalis. Proceedings of 3rd USM-JIRCUS Joint International Symposium, Lignocellulose: Material for the Future in the Tropics 9-11 March, Penang, Malaysia (CD version)

    Short Communications. Short communication also contain abstract. The list of references should not exceed 10. The presentation of Short Communications should contain headings such as Introduction, Materials and Methods, Results and Discussion, etc.

  12. Electronic Submission
    The original manuscript must be submitted on a disk or a CD together with three identical hard copies. The manuscript (title page, abstract, text, figures, tables, references) needs to be saved into a single file. The preferred storage medium is a 3.5" diskette or a recordable CD. Please, save your file in the Word processor format. Label the diskette/CD with your name. After final acceptance, 2 hard copies of the manuscript and a copy on diskette/CD must be submitted to the Editor-in-Chief.

  13. Proofs and Reprints
    Proofs will be sent to the corresponding author for correction. They should be carefully checked for typesetting errors and returned to the publisher within 48 hours upon receipt. Following this period, the article will be published as it has appeared in the first proofs.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The authorship statement form has been read and accepted by all the contributing authors and a scanned version of it (in GIF, PNG, JPEG or PDF format) will be submitted as a supplementary file later during this submission process. The authorship statement form is available during the online submission process or can be obtained from the Editor.
  2. The submission file is in Microsoft Word or RTF document file format.
  3. The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  4. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  5. The text, if submitted to a peer-reviewed section (e.g., Articles), has had the authors' names removed. If an author is cited, "Author" and year are used in the bibliography and footnotes, instead of author's name, paper title, etc. The author's name has also been removed from the document's Properties, which in Microsoft Word is found in the File menu.
  6. A structured abstract of no more than 250 words has been included with the text. A list of three to five keywords has been given, and placed after the Abstract.
  7. Listed references (i.e. bibliography at the end) are based on the journal requirements style.

Copyright Notice

As a condition of publication, all authors must transfer copyright to the Department of Pharmacy. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission, and that the final version of the manuscript has been seen and approved by them.

Each author must agree to this statement

Authorship: This manuscript is the original work of the authors, each of whom has read and approved of the work. Each author satisfied the requirements contained in 'Author Guidelines' having participated sufficiently in the work to take public responsibility for the content. This participation includes:

  • Conception or design of the study, or analysis and interpretation of data, or both
  • Drafting the article or revising it for critically important intellectual content
  • Approval of the final 'to be published' version

All authors must take responsibility for the integrity of the work. Participating solely in the collection of data does not justify authorship.

Prior publication: This work is not currently under consideration by any other journal. Information about prior publication of any part of this work, or inclusion of patients detailed herein in any other work, has been provided in the cover letter.

Conflict of interest: Details of any financial or other relationship between any author and any other party that may lead to a conflict of interest with the subject or any materials mentioned in this article have been disclosed in the cover letter.

Privacy Statement

Bangladesh Journals Online (BanglaJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, BanglaJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to BanglaJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 18 May 2018)